NYSE:AMPE

Ampio Pharmaceuticals Stock Predictions

etoro logo Buy AMPE
*Your capital is at risk
$0.183
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AMPE Prediction Chart

AMPE Predictions History

Latest community submissions for AMPE.
Predictor Target Session Target Price Result Direction Accuracy Score
Rick Murphy Rick Murphy @RickMurphy.172536
Dec 3, 2020 $1.75 -99.46% $1.08 X 37.96% 1
JS JS Pro
Dec 2, 2020 $0.89 -99.71% $1.03 V 86.70% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 28, 2020 $0.96 -99.65% $0.92 X 95.98% 0
JS JS Pro
Sep 28, 2020 $0.98 -99.64% $0.92 X 93.37% 0
iHustle84 iHustle84 Pro
Sep 28, 2020 $1.00 -99.64% $0.92 X 91.30% 0
JS JS Pro
Mar 6, 2020 $0.604 -99.65% $0.585 V 96.72% 1
Rachel Rachel @Rachel.98108
Mar 6, 2020 Bearish $0.585 V 1
May 6, 2019 $0.591 -99.64% $0.550 X 92.55% 0
May 3, 2019 $0.551 -99.68% $0.566 V 97.28% 0
Apr 29, 2019 $0.535 -99.69% $0.566 V 94.57% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AMPE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AMPIO PHARMACEUTICALS INC
Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE